Enhance your PD-L1 expertise with Agilent’s PD-L1 On-Demand Webinar Series
The four-part Precision Pathology Insights series covers topics that matter to pathologists:
- Find Your Companion – “The Value of Companion Diagnostics (CDx) Assays in the Complex Environment of PD-L1 Testing”
- Know Your Score – “The Rationale Behind the Scoring Systems for PD-L1 IHC to Determine Patients Eligible for KEYTRUDA® (pembrolizumab)”
- Elevate Your Confidence – “External Quality Assurance of PD-L1 Assays: The NordiQC Experience”
- Coordinate Your Care – “The Pathologist and the Oncologist: Working Together on PD-L1 to Improve Patient Treatment”
Watch the PD-L1 Webinar Series >>
KEYTRUDA is a registered trademark of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co. Inc.
